Fuad Bahram
Impact in
- Molecular Biology top 2%
- Ubiquitin and proteasome pathways
- Advanced biosensing and bioanalysis techniques
- Angiogenesis and VEGF in Cancer
- Genomics and Chromatin Dynamics
- RNA modifications and cancer
- Protein Degradation and Inhibitors
- Cell Biology top 2%
- Microtubule and mitosis dynamics
Papers in
- Oncology 11
- Cancer-related Molecular Pathways 9
- Cytokine Signaling Pathways and Interactions 1
-
- Ubiquitin and proteasome pathways 10
- Cell death mechanisms and regulation 4
- Angiogenesis and VEGF in Cancer 4
- Genomics, phytochemicals, and oxidative stress 1
- Co-authors
- Lars‐Gunnar LarssonPer HydbringOla SöderbergMalin JarviusKarl‐Johan LeuchowiusMats GullbergKarin RidderstråleKenneth Wester
- Journals
- Blood (4 papers)Oncogene (2 papers)Nature Methods (1 paper)Molecular Cancer Therapeutics (1 paper)Leukemia (1 paper)
- Partner nations
- SwedenGermanyUnited States
In The Last Decade
Fuad Bahram
19 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Molecular Biology 2.7k
- Cell Biology 601
- Oncology 917
- Cancer Research 315
- Immunology and Allergy 116
Countries citing papers authored by Fuad Bahram
This map shows the geographic impact of Fuad Bahram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuad Bahram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuad Bahram more than expected).
Fields of papers citing papers by Fuad Bahram
This network shows the impact of papers produced by Fuad Bahram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuad Bahram. The network helps show where Fuad Bahram may publish in the future.
Co-authors
The 25 scholars most cited alongside Fuad Bahram, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 11 | |
| 2 | Direct effects of pure nicotine, cigarette smoke extract, Swedish-type smokeless tobacco (Snus) extract and ethanol on human normal endothelial cells and fibroblasts. | 2011 | 28 |
| 3 | 2010 | 139 | |
| 4 | 2009 | 49 | |
| 5 | 2009 | 158 | |
| 6 | 2009 | 95 | |
| 7 | 2008 | 26 | |
| 8 | 2007 | 21 | |
| 9 | 2007 | 23 | |
| 10 | Direct observation of individual endogenous protein complexes in situ by proximity ligation Hit paper breakdown → | 2006 | 1899 |
| 11 | 2003 | 399 | |
| 12 | 2003 | 250 | |
| 13 | 2002 | 121 | |
| 14 | 2001 | 10 | |
| 15 | 2000 | 213 | |
| 16 | 1999 | 21 | |
| 17 | 1999 | 3 | |
| 18 | 1997 | 1 | |
| 19 | 1997 | 38 |
About Fuad Bahram
Fuad Bahram is a scholar working on Oncology, Molecular Biology, Biochemistry, Immunology and Allergy and Cancer Research, having authored 19 papers that have together received 3.5k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (10 papers), Cancer-related Molecular Pathways (9 papers), Cell death mechanisms and regulation (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Axon Guidance and Neuronal Signaling (2 papers), Cytokine Signaling Pathways and Interactions (1 paper), Genomics, phytochemicals, and oxidative stress (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Molecular Biology (2.7k citations), Cell Biology (601 citations), Oncology (917 citations), Cancer Research (315 citations) and Immunology and Allergy (116 citations). Fuad Bahram has collaborated with scholars based in Sweden, Germany and United States. Frequent co-authors include Lars‐Gunnar Larsson, Per Hydbring, Ola Söderberg, Malin Jarvius, Karl‐Johan Leuchowius, Mats Gullberg, Karin Ridderstråle, Kenneth Wester, Jonas Jarvius and Ulf Landegren. Their work appears in journals such as Blood, Oncogene, Nature Methods, Molecular Cancer Therapeutics and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.